DEVELOPMENT OF A SMALL MOLECULE ANTI-MISFOLDING DRUG FOR FRONTOTEMPORAL DEGENERATION

$2,977,166FY2022Defense Health AgencyDOD

Treventis Corporation

Investigators

View source on USAspending →